AstraZeneca Submits Seroquel sNDA For Bipolar Depression Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
If approved, Seroquel would be the only agent indicated to treat both depressive and manic episodes associated with bipolar disorder.